Phase IIb Clinical Trial Results A variety of HLA types are predicted to associate with GP2 based on binding algorithms, and such binding can be tested in preclinical experiments. However, HLA-A*02 is ...
Because of natural selection, different alleles are more likely to confer a survival advantage in different environments. Cycles of infectious disease prevalence and virulence often reflect natural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback